Cutting edge: Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion

Journal of Immunology

Volumn 161, Issue 4, 1998, Pages 1589-1593

  Collinge, Mark ^a,c   Pardi, Ruggero ^b   Bender, Jeffrey R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN; HLA DR ANTIGEN; MESSENGER RNA; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; RNA ANALYSIS; SIGNAL TRANSDUCTION; TRANSACTIVATION; ADULT; BIOSYNTHESIS; CELL CULTURE; COCULTURE; CYTOLOGY; GENE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MUTAGENESIS; PHYSIOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADULT; CELL ADHESION; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; MUTAGENESIS; NUCLEAR PROTEINS; RNA, MESSENGER; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 0032528799     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107.
2. + responses to human allogeneic microvascular endothelium. Circ. Res. 69:1269.
3. Pardi, R., J. R. Bender, and E. G. Engelman. 1987. Lymphocyte subsets differentially induce class II human leukocyte antigens on allogeneic microvascular endothelial cells. J. Immunol. 139:2585.
4. Pober, J. S., and M. A. J. Gimbrone. 1982. Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc. Natl. Acad. Sci. USA 79:6641.
5. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
6. Chang, C.-H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II trans-activator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
7. Meraz, M. A., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
8. Lee, Y.-J., and E. N. Benveniste. 1996. Stat1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J. Immunol. 157:1559.
9. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330.
10. II32. Nucleic Acids Res. 25: 2522.
11. Mahanta, S. K., T. Scholl, F.-C. Yang, and J. L. Strominger. 1997. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94:6324.
12. Watson, C. A., P. Petzelbauer, J. Zhou, R. Pardi, and J. R. Bender. 1995. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-γ-dependent and -independent mechanisms. J. Immunol. 154:3222.
13. Lanier, L. L., E. G. Engelman., P. Gatenby, G. F. Babcock, N. L. Warner, and L. A. Herzenberg. 1983. Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multi-parameter analysis and flow cytometry. Immunol. Rev. 74:143.
14. Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456.
15. Mao, C., D. Davies, I. M. Kerr, and G. R. Stark. 1993. Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon γ. Proc. Natl. Acad. Sci. USA 90:2880.
16. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
17. Lian, R. H., G. J. Kotwal, S. R. Wellhausen, L. A. Hunt, and D. E. Justus. 1996. IFN-γ-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. J. Immunol. 157:864.
18. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
19. Lennon, A.-M., C. Ottone, G. Rigaud, L. L. Deaven, J. Longmire, M. Fellous, R. Bono, and C. Alcaide-Loridan. 1997. Isolation of a B-cell-specific promoter for the class II transactivator. Immunogenetics 45:266.
20. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851.
21. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFN-γ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563.
22. McKendry, R., J. John, D. Flavell, M. Muller, I. M. Kerr, and G. R. Stark. 1991. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both α and γ interferons. Proc. Natl. Acad. Sci. USA 88:11455.
23. Muller, M., J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. G. Harpur, G. Barbieri, B. A. Witthuhn, C. Schindler, S. Pellegrini, A. F. Wilks, J. N. Ihle, G. R. Stark, and I. M. Kerr. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366:129.
24. Chirthaworn, C., S. A. Tibbetts, M. A. Chan, and S. H. Benedict. 1995. Cross-linking ICAM-1 on T cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J. Immunol. 155:5479.
25. Durieu-Trautmann, O., N. Chaverot, S. Cazaubon, A. D. Strosberg, and P.-O. Couraud. 1994. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J. Biol. Chem. 269:12536.
26. Holland, J., and T. Owens. 1997. Signaling through intercellular adhesion molecule-1 (ICAM-1) in a B cell lymphoma line. J. Biol. Chem. 272:9108.
27. Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
28. Douhan, J., III, R. Lieberson, J. H. M. Knoll, H. Zhou, and L. H. Glimcher. 1997. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator. J. Exp. Med. 185:1885.
29. Zhou, H., H. S. Su, X. Zhang, J. Douhan III, and L. H. Glimcher. 1997. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:4741.
30. Nandan, D., and N. E. Reiner. 1997. TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J. Immunol. 158:1095.
31. Chin, K.-C., G. G.-X. Li, and J. P.-Y. Ting. 1997. Importance of acidic, proline/ serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501.